More than 1350 Australian women have won a seven-year-old class-action lawsuit against Johnson & Johnson (J&J) of New Brunswick, New Jersey, USA, for misleading patients and surgeons about the risks of the surgical product manufacturer's pelvic mesh implants for the repair of pelvic organ prolapse and the treatment of stress urinary incontinence. Australia's Federal Court found in November 2019 that J&J subsidiary Ethicon of Somerville, New Jersey, USA, had sold the devices without warning women about the "gravity of the risks" their implantation posed, and was "negligent" in rushing the products to market before proper testing.
展开▼
